首页> 美国卫生研究院文献>OncoTargets and therapy >Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer

【2h】

Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer

机译：血清基质金属蛋白酶9的连续测量以监测晚期非小细胞肺癌患者的化疗反应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundMatrix metalloproteinase 9 (MMP-9) plays an important role in tumor invasion and metastasis, including lung cancer. However, whether variations in serum MMP-9 levels can serve as a biomarker for monitoring chemotherapy curative effect remains unclear. This study was designed to investigate the association between variations in serum MMP-9 levels and chemotherapy curative effect in patients with lung cancer.

机译：背景基质金属蛋白酶9（MMP-9）在包括肺癌在内的肿瘤侵袭和转移中起着重要作用。然而，尚不清楚血清MMP-9水平的变化是否可以作为监测化疗疗效的生物标志物。这项研究旨在调查肺癌患者血清MMP-9水平的变化与化疗疗效之间的关系。

著录项

期刊名称 OncoTargets and therapy
作者
Xiaojuan Qiao; Xiaoran Zhai; Jinghui Wang; Xiaoting Zhao; Xinjie Yang; Jialin Lv; Li Ma; Lina Zhang; Yue Wang; Shucai Zhang; Wentao Yue;
展开▼
作者单位

展开▼
年(卷),期 2016(9),-1
年度 2016
页码 3299–3305
总页数 7
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
prognosis lung adenocarcinoma lung squamous carcinoma chemotherapy treatment monitoring;

机译：预后;肺腺癌;肺鳞癌;化学疗法;治疗监测;
入库时间 2022-08-17 12:28:16

相似文献

外文文献
中文文献
专利

1. Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer [J] . Xiaojuan Qiao, Xiaoran Zhai, Jinghui Wang, OncoTargets and therapy . 2016,第6期

机译：血清基质金属蛋白酶9的连续测量以监测晚期非小细胞肺癌患者的化疗反应
2. Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment. [J] . Jumper C, Cobos E, Lox C Respiratory medicine . 2004,第2期

机译：治疗前对晚期小细胞肺癌或非小细胞肺癌患者的血清基质金属蛋白酶9（MMP-9）和基质金属蛋白酶1组织抑制剂（TIMP-1）的测定。
3. Phase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancer [J] . Jian Ming Xu, Yu Han, Yue Min Li, BMC Cancer . 2006,第1期

机译：中国晚期非小细胞肺癌患者对化疗有轻微反应或部分反应后进行序贯吉非替尼的II期临床试验
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. Phase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancer [O] . Jian Ming Xu, Yu Han, Yue Min Li, 2006

机译：中国晚期非小细胞肺癌患者对化疗有轻微反应或部分反应后序贯吉非替尼的II期临床试验
7. Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment [O] . Jumper Cynthia, Cobos Everardo, Lox Charles 2004

机译：治疗前对晚期小细胞肺癌或非小细胞肺癌患者的血清基质金属蛋白酶9（MMP-9）和基质金属蛋白酶1组织抑制剂（TIMP-1）的测定

Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer

摘要

著录项

相似文献

相关主题

期刊订阅